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Objectives. We attempted to establish a relation between the 
atrial conduction time assessed by the signal-averaged P wave 
electrocardiogram nd episodes of paroxysmal trial fibrillation 
in patients with the Wolff.Parkinson-White syndrome. 
Background. The incidence of paroxysmal trial fibrillation is 
higher in patients with the Woifl'-Parkinson-White syndrome than 
in normal persons. However, the role of intraatrial conduction 
delay in precipitating the disorganization of atrial rhythm is not 
completely understood. 
Methods. The total duration of the signal-averaged P wave and 
the P wave in standard lead II was evaluated after successful 
radiofrequency atheter ablation in 28 patients with the Wolff- 
Parkinson-White syndrome. The data obtained from 17 patients 
(61%) with a documented history of prior paroxysmal atrial 
fibrillation (group 1) were compared with those obtained from 11 
patients (39%) without a history of atrial fibrillation (group 2). 
Both groups were further compared with a normal control popu- 
lation. 
Results. The mean -+ SD signal-averaged P wave duration in 
group 1 was 141.94 + 9.47 ms (range 130.0 to 171.0). Fourteen 
patients (82%) in this group showed aP wave duration > 135.0 ms. 
In group 2, the signal-averaged P wave duration was 126.64 _+ 
8.72 ms (range 111.0 to 136.0). Only one patient in this group (9%) 
showed a P wave duration > 135.0 ms (p < 0.000, group 1 vs. 
group 2). The signal-averaged P wave duration in the control 
group was 124.46 _+ 4.49 ms (range 115.0 to 129.5; p < 0.000, group 
1 vs. the control group; p < 0.454, group 2 vs. the control group). The 
P wave duration in lead II was 92.06 _+ 8.85 ms in group 1 and 
9227 ,+ 7.86 ms in group 2 (p < 0.949). Using a cutoff value of 
< 135.0 ms for a normal signal-averaged P wave duration, the method 
had a sensitivity and specificity and positive and negative predictive 
values of 82%, 91%, 93% and 77%, respectively, for identifying 
patients with clinical paroxysmal trial fibrillation. 
Conclusions. In the current study, the signal-averaged P wave 
showed a prolonged intraatrial conduction time in patients with 
the Wolff-Parkinson-White syndrome and paroxysmal atrial fi- 
brillation. These patients can be differentiated from those with the 
pre-excitation syndrome without clinical atrial fibrillation as well 
as from normal subjects. The prolonged intraatrial conduction 
time may serve as an atrial substratum for development and 
maintenance of the fibrillatory state. 
(J Am CoU Cardio11995;26:1310-4) 
Patients with the Wolff-Parkinson-White syndrome have a 
higher incidence of spontaneous paroxysmal atrial fibrillation 
than that of normal persons (1). If the properties of the 
accessory pathway allow rapid conduction, paroxysmal atrial 
fibrillation can be a potentially life-threatening arrhythmia (2). 
Recent work has demonstrated the clinical utility of the 
signal-averaged P wave electrocardiogram (ECG) in studying 
atrial activation conduction times. These studies (3,4) reported 
that a prolonged signal-averaged P wave duration is associated 
with high sensitivity and specificity for identifying patients at 
risk for the development of paroxysmal atrial fibrillation. 
However, ability to obtain the signal-averaged P wave duration 
in patients with the Wolff-Parkinson-White syndrome is lim- 
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ited by the presence of the delta wave. When ventricular 
pre-excitation exists, the delta wave can conceal the end of the 
P wave, affecting the correct determination of P wave duration. 
This problem does not occur after successful radiofrequency 
ablation of the anomalous pathway or during normal conduc- 
tion in cases of intermittent pre-excitation. In these two 
situations, the disappearance of the delta wave allows a precise 
assessment of P wave duration. 
The purpose of this study was to evaluate, using the 
signal-averaged P wave ECG, the intraatrial conduction time 
of patients with the pre-excitation syndrome who had previ- 
ously undergone successful radiofrequency catheter ablation. 
We compared the findings in patients with and without docu- 
mented episodes of paroxysmal atrial fibrillation and in a 
control group of normal subjects. 
Methods  
Patient selection. We prospectively analyzed the signal- 
averaged P wave ECG of 28 consecutive patients with the 
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Table 1. Individual Patient Data 
P Wave Duration (ms) 
Pt. Age (yr)/ AP Arrhy Signal- 
No. Gender Site Type Averaged Lead I1 
1" 22/M R RT, PAF 150.5 100.0 
2* 58/M R RT, PAF 171.0 120.0 
3 16/M R RT 120.0 100.0 
4 27/M L RT, PAF 135.0 90.0 
5 30/M L RT, PAF 140.5 85.0 
6 45/M L RT 122.0 80.0 
7 29/F L RT 125.5 85.0 
8 47/F R RT 112.0 80.0 
9 3I/F L RT ll 1.0 9(}.0 
10 40/M L RT, PAF 135.5 90.0 
11 56/M L RT 136.0 100.0 
12 45/F L RT 130.0 95.0 
13 38/M L RT, PAF 137.0 90.0 
14 20/F L RT 133.0 100.0 
15 31/M L RT, PAF 139.5 95.0 
16 15/q 7 R RT 124.5 90.0 
17 27/M L RT, PAF 139.0 90.0 
18 23/'1:: R RT 130.0 95.11 
19 52/F L RT, PAF 139.0 85.0 
20 41/M L RT, PAF 152.0 90.0 
21 22/I= R RT, PAF 148.0 100.0 
22 44/M R RT, PAF 144.0 95.0 
23 23/M L RT, PAF 130.0 85.0 
24 46/F L RT 134.0 100.0 
25 38/M L RT, PAF 141.0 80.0 
26 25/M L RT, PAF 133.5 90.0 
27 35/M L RT, PAF 138.5 90.0 
28 44/M L RT, PAF 139.11 90.0 
*Recurrent paroxysmal atrial fibrillation (PAF). AP = anomalous path- 
way; Arrhy - paroxysmal supraventricular t chycardia: F = female; L = left; 
M = male; Pt - patient; R = right; RT - atrioventricular reciprocating 
tachycardia. 
Wolff-Parkinson-White syndrome, with a fixed degree of ven- 
tricular pre-excitation, who underwent radiofrequency abla- 
tion. There were 18 men and 10 women with a mean age _+ SD 
of 34.6 _+ 12.0 years; 20 patients had a left-sided and 8 had a 
right-sided accessory pathway. Group 1 comprised 17 patients 
(61%; 15 men, 2 women; mean age 35.1 + 10.6 years) with 
previous documented pisodes of paroxysmal trial fibrillation. 
In this group, 13 patients had a left-sided anomalous pathway. 
Group 2 comprised 11 patients (39%; 8 women, 3 men; mean 
age 33.9 __ 14.4 years) without clinical atrial fibrillation; 7 of 
these 11 patients had a left-sided accessory pathway. The 
results in these two groups were compared with the results 
obtained in an age-matched normal control group of 12 
patients (7 women, 5 men; mean age 33.1 _+ 10.2 years). 
To preclude left atrial enlargement, we excluded from the 
study patients with any of the following conditions: 1) conges- 
tive heart failure, 2) systemic hypertension (blood pressure 
->160/90 mm Hg), 3) previous myocardial infarction, 4) con- 
genital heart disease, 5) cardiomyopathy, 6) systemic diseases. 
All patients who met these entry criteria had a left atrial size 
<4.0 cm by echocardiography and were withdrawn from all 
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Figure I. Demonstration ofanomalous pathway ablation during atria] 
fibrillation. Despite successful ablation, the atrial tachyarrhythmia 
persists. RF .... indicates the application ofradiofrequency energy. 
antiarrhythmic medications at least 5 half-lives before the 
ablation and the signal-averaged procedures. Individual data 
are shown in Table 1. 
Accessory pathway ablation. Radiofrequency atheter ab- 
lation protocols were approved by the Scientific Board of our 
institutions. Written informed consent was obtained from all 
patients. For left-sided anomalous pathways, the procedure 
was performed by using the retrograde arterial approach, with 
the catheter positioned on the ventricular side of the mitral 
annulus. Energy was delivered at sites that recorded the 
shortest atrioventricular (AV) times. The predictor of success 
was the interval between the onset of the local ventricular 
electrogram and the onset of the delta wave in the surface 
ECG, with or without anomalous pathway potentials, recorded 
in at least five similar pre-excited beats. For right-sided acces- 
so W pathways, a transvenous femoral approach was used and 
ablation was performed at the atrial aspect of the tricuspid 
annulus. In five patients the ablation was performed uring 
paroxysmal atrial fibrillation (5) without interruption of the 
atrial tachyarrhythmia (Fig. 1). Successful ablation was 
achieved in all 28 patients tudied with the averaged P wave 
method. The data from the ablation procedures in groups 1 
and 2 were compared. 
Standard ECG methodology. For each patient, a standard 
12-lead ECG was recorded immediately before the signal- 
averaged P wave. The records were obtained at a paper speed 
of 25 mm/s and a signal size of 10 mm/mV. The total P wave 
duration was manually measured in lead II. 
Signal-averaged methodology. The signal-averaged P wave 
was recorded according to the method proposed by Guidera 
and Steinberg (3) using the Predictor II system from Corazonix 
Corporation. The recordings were performed between the 7th 
and the 14th day after the ablation procedure to allow atrial 
functional recovery time after paroxysmal trial fibrillation and 
cardioversion (6). An orthogonal lead system identical to that 
used in ventricular signal-averaged ECGs was used (7). The 
QRS complex was used as the trigger of the signal-averaging 
process. To expose the P wave, the fiducial point was shifted to 
the right at a 450-ms window. The signal was digitized at a 
frequency of 2,000 samples/s with 16-bit accuracy. A sinus P 
wave template was manually selected, with a correlation coef- 
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Figure 2. Examples of the signal-averaged P wave in the control group 
(A) and in patients with the Wolff-Parkinson-White (WPW) syndrome 
without and with paroxysmal trial fibrillation (B and C, respectively). 
The upper panel shows the corresponding P wave in lead II (L2) 
before and after catheter ablation. 
ficient of 99%. The correlation window width was 25 ms, with 
<0.3-~V noise at the end of the procedure. To improve the 
visualization of the low amplitude components of the atrial 
activation, a least square fit filter with a window width of 
100 ms was applied to the averaged output. P wave onset and 
offset were determined manually as the first atrial deflection 
from the baseline noise level and the return of the atrial signal 
to the baseline level, respectively. The X, Y and Z filtered 
leads were combined into a P vector magnitude. The total P 
wave duration, in ms, was manually determined from the P 
vector magnitude. 
Signal-averaged P wave analysis. The signal-averaged P 
waves were prospectively analyzed in blinded fashion; two 
different physicians reviewed the data without knowledge of 
previous clinical paroxysmal atrial fibrillation. 
Follow-up. All patients were carefully followed up during 
outpatient clinic visits, when symptoms that might indicate 
atrial fibrillation recurrence were investigated. Long-term ab- 
lation success was considered achieved if no evidence of 
recurrences of the clinical arrhythmia or a return of pre- 
excitation were diagnosed. 
Statistical analysis. Data arc presented as mean value _+ 
1 SD. One-way analysis of variance was used for group 
comparisons. Significance refers to a value of p < 0.05. The P 
wave duration from the vector magnitude was used to deter- 
mine the sensitivity, specificity, and positive and negative 
predictive values of the signal-averaged P wave for identifying 
patients with clinical paroxysmal atrial fibrillation. 
Resu l ts  
Baseline clinical data and radiofrequency ablation charac- 
teristics. The groups with (group 1) and without (group 2) 
clinical atrial fibrillation did not differ in age, site of accessory 
pathway, number of radiofrequency applications required 
(4.45 _+ 2.54 vs. 3.36 -+ 2.58, p < 0.330) or total delivered 
energy (110.45 _+ 52.75 vs. 82.91 + 52.72 W, respectively, p < 
0.235). 
P wave duration in standard lead II. P wave duration in 
lead lI ranged from 85.0 to 120.0 ms (mean 92.06 + 8.85) in 
group 1 and from 80.0 to 100 ms (mean 92.27 _+ 7.86) in 
group 2 (p < 0.949). Three patients in group 1 (Cases 1, 25 
and 28) and one patient in group 2 (Case 24) showed 
notched P waves. 
Signal-averaged P wave analysis. P wave duration in group 
1 ranged from 130.0 to 171.0 ms (mean 14t.94 _+ 9.47); 14 
patients (82%) in this group had values >135.0 ms. P wave 
duration in group 2 ranged from 1tl.0 to 136.0 ms (mean 
126.64 _+ 8.72), only one patient (9%) had a value >135.0 ms. 
In the control group, P wave duration ranged from 114.0 to 
129.5 ms (mean 124.46 _ 4.49). Examples of the signal- 
averaged P wave are shown in Figure 2 and the results are 
expressed graphically in Figure 3. The P wave duration com- 
parisons between groups 1 and 2 reached statistical signifi- 
cance (p < 0.000) as did the comparisons between group 1 and 
the control group (p < 0.000). There were no statistical 
differences between group 2 and the control group (p < 0.454). 
To assess the consequences of radiofrequency application 
over the atrial tissue, we examined the results of the signal- 
averaged P wave duration considering only the 20 patients with 
a left-sided anomalous connection who underwent energy 
delivery, on the ventricular side of the mitral annulus. Among 
patients with a left-sided connection in group 1, P wave 
duration ranged from 130.0 to 152.0 ms (mean 138.42 +_ 5.12); 
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Figure 3. Signal-averaged P wave duration i the three 
study groups. A normal Pwave duration was considered 
to be <135.0 ms. Group 1 = 17 patients with the 
Wolff-Parkinson-White syndrome with paroxysmal 
atrial fibrillation; Group 2 = 11 patients with the 
Wolff-Parkinson-White syndrome without paroxysmal 
atrial fibrillation; Control = 12 patients without the 
Wolff-Parkinson-White syndrome. 
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among those in group 2, it ranged from 111.0 to 136.0 ms 
(mean 127.36 _+ 8.73) (p < 0.002). 
With a cutoff value for normal P wave duration of 
<135.0 ms, the sensitivity, specificity and positive and negative 
predictive values of the method were 82%, 91%, 93% and 77% 
respectively, for identifying patients with clinical paroxysmal 
atrial fibrillation. 
P wave in lead II and signal-averaged P wave. In all 
patients, P wave duration after signal averaging was signifi- 
cantly longer than P wave duration measured in standard lead 
II. In group 1, the increase in P wave duration ranged from 
43.5 to 62.0 ms (mean 50.15 _+ 5.82). In group 2, it ranged from 
21.0 to 42.0 ms (mean 34.36 ___ 5.35) (p < 0.000). In the control 
group, it ranged from 25.0 to 42.0 ms (mean 35.67 __ 5.38) (p < 
0.000, group 1 versus control group; p < 0.567, group 2 versus 
control group). 
Follow-up. After a mean follow-up interval of 8 months 
(range 2 to 18), three patients (18%) from group 1 had docu- 
mented recurrent paroxysmal trial fibrillation; the respective P 
wave duration in these patients was 150.5, 171.0 and 139.0 ms 
(Table 1). There were no arrhythmia recurrences ingroup 2. 
Discuss ion  
The clinical incidence rate of paroxysmal trial fibrillation 
in patients with Wolff-Parkinson-White syndrome has been 
reported (1) to range from 12% to 32%. However, the reasons 
for this high rate are not clear. It has been suggested (8) that 
the association of mechanical factors such as atrial stretch, 
hypoxemia nd AV reciprocating tachycardia may be precipi- 
tating factors. Other studies (9,10) have suggested that fast 
retrograde conduction over an anomalous pathway or the 
presence of atrial premature beats during orthodromic recip- 
rocating tachycardia may be precipitating factors for the 
development of acute episodes of atrial fibrillation. These two 
situations could induce atrial activation during incomplete 
recovery of the atrial tissue, leading to the initiation of 
intraatrial reentry, and subsequent atrial fibrillation. The de- 
creased incidence of paroxysmal atrial fibrillation reported 
after surgical (11) or catheter (12) elimination of the accessory 
pathway conduction suggests participation ofsuch conduction 
in the genesis of this atrial tachyarrbythmia. All these findings 
support he hypothesis that the anomalous pathway mediated 
the episodes of atrial fibrillation. However, after successful 
elimination of the anomalous connection, some patients may 
still have spontaneous sustained episodes of atrial fibrillation 
with no evidence of accessory pathway conduction, even after 
adenosine infusion. In the present study, the incidence of 
recurrent paroxysmal atrial fibrillation after radiofrequency 
ablation was 17.6%, a fact suggesting that the accessory 
pathway is not always the main cause of atrial fibrillation. 
Furthermore, as observed in our patients, successful ablation 
of the accessory pathway, performed uring paroxysmal trial 
fibrillation, does not result in termination of the fibrillatory 
episodes (Fig. 1), even after 60 rain of the procedure. Thus, the 
anomalous pathway is probably responsible for initiation of the 
acute pisodes of atrial fibrillation but not for their maintenance. 
Intraatrial conduction disturbances have been demon- 
strated (9) in patients with the Wolff-Parkinson-White 
syndrome and paroxysmal trial fibrillation assessed by elec- 
trophysiologic studies. Some patients with ventricular pre- 
excitation exhibit ECG P wave morphologic disturbances, and 
the causes of such alterations have been extensively discussed 
(13). In several patients, the P waves are distinctly notched, 
suggesting the presence of intraatrial conduction disturbances. 
Thus, as previously discussed, it is very possible that the 
anomalous pathway plays a role in the initiation of atrial 
fibrillation by rapid retrograde conduction of the electrical 
impulse during AV reciprocating tachycardia sothat it reaches 
the atria during the vulnerable period. However, not only the 
presence of the anomalous connection itself but the associated 
delayed conduction in the atrial tissue could facilitate and 
perpetuate r entry (10). 
The delayed intraatrial conduction time represents an 
important factor precipitating acute episodes of atrial fibrilla- 
tion (14). It has been demonstrated (15) that he inducibility of 
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atrial fibrillation before and after radiofrequency ablation of 
the anomalous pathway is independent of the presence of the 
accessory connection and similar to that in the general popu- 
lation. Thus, supporting the results obtained from electro- 
physiologic studies (10), our data strongly suggest the presence 
of delayed atrial activation in patients with the Wolff- 
Parkinson-White syndrome and paroxysmal trial fibrillation. 
Using a more sensitive technique to study atrial activation 
time, we observed a higher incidence of conduction delay in 
these patients. In addition, no patient had an enlarged left 
atrium as assessed by echocardiography. Thus, it is interesting 
to speculate that, from the same anatomic substratum (con- 
duction delay), the episodes of atrial fibrillation would be more 
frequent in patients with the Wolff-Parkinson-White syndrome 
than in the general population because the presence of the 
accessory pathway itself could facilitate initiation of the fibril- 
latory state. The conduction delay in the atrial tissue would 
further allow perpetuation f atrial reentry and the fibrillatory 
mechanisms. This hypothesis is supported by the greater 
increase in P wave duration seen in patients in group I than in 
group 2 when the signal-averaged P wave and the P wave in 
lead II were compared (50.15 ± 5.88 vs. 34.36 ± 5.35 ms, p < 
0.000). These findings uggest that in patients with paroxysmal 
atrial fibrillation, the impairment in atrial conduction is high- 
lighted by the low amplitude signals that are detected by the 
averaging process. 
Limitations of the study. One could argue the conse- 
quences of radiofrequency application at the AV groove and 
its possible implications for the results observed here. How- 
ever, the majority of patients had a left-sided connection and 
consequently the energy was delivered at the ventricular 
insertion of the pathway, during a retrograde aortic approach. 
Radiofrequeney l sions are small (4 to 5 ram, depending on the 
tip of the catheter used during the procedure) (16) and could 
not interfere with P wave duration. Indeed, all patients en- 
rolled in this study underwent a Doppler echocardiographic 
study before and after the ablation in which no valvular 
insutficiency was diagnosed. In addition, the results obtained 
when we analyzed only patients with a left-sided anomalous 
pathway were almost he same as those observed in the total 
group, and there were no correlations ineither group between 
P wave duration and the number of radiofrequency applica- 
tions or the amount of energy delivered. 
Clinical implications. To date, with clinical paroxysmal 
atrial fibrillation has developed in 3 of 17 patients after 
ablation; all 3 patients had a P wave duration > 135.0 ms, thus 
reflecting the accuracy of the signal-averaged P wave method 
for detecting patients likely to have this type of atrial arrhyth- 
mia. Unfortunately, the method has limited clinical applica- 
tion, because the delta wave overshadows the correct measure- 
ment of P wave duration. However, as a noninvasive 
procedure, it can contribute to the understanding of the 
complex mechanisms involved in the genesis of paroxysmal 
atrial fibrillation. 
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